Arisaph Pharmaceuticals Garners $10,000,000 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=849f1ca0-9beb-47c5-8878-daa9b738268d
Date
11/1/2013
Company Name
Arisaph Pharmaceuticals
Mailing Address
100 High Street Boston, MA 02110
Company Description
Arisaph Pharmaceuticals, Inc. is an emerging drug discovery and design biopharmaceutical company located in Boston, Massachusetts, an internationally recognized center of biotechnology. The company utilizes proprietary drug discovery platforms to develop differentiated drugs that are highly potent and act on select targets for the treatment of a variety of diseases.
Website
http://www.arisaph.com
Transaction Type
Venture Equity
Transaction Amount
$10,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
M&A Terms
Venture Investor
Undisclosed